Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

What Are the Benefits and Harms of Risk Stratified Screening as Part of the NHS Breast Screening Programme: Study Protocol for a Multi-site Non-randomised Comparison of BC-Predict Versus Usual Screening

NCT04359420 is registered in ClinicalTrials.gov with University of Manchester as lead sponsor.

NCT NCT04359420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04359420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
What Are the Benefits and Harms of Risk Stratified Screening as Part of the NHS Breast Screening Programme: Study Protocol for a Multi-site Non-randomised Comparison of BC-Predict Versus Usual Screening
Lead sponsor
University of Manchester
Phase
Not applicable
Overall status
Completed
Start date
August 1, 2019
Completion date
June 30, 2022
Enrollment
32,298 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer